<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03736642</url>
  </required_header>
  <id_info>
    <org_study_id>18CH109</org_study_id>
    <secondary_id>2018-A01731-54</secondary_id>
    <nct_id>NCT03736642</nct_id>
  </id_info>
  <brief_title>Study of the Microbiological Profile of Stool in Patients With Anorexia Nervosa</brief_title>
  <acronym>ANOSTOOL</acronym>
  <official_title>Study of the Microbiological Profile of Stool in Patients With Anorexia Nervosa</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Centre Hospitalier Universitaire de Saint Etienne</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Centre Hospitalier Universitaire de Saint Etienne</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Anorexia nervosa is an eating disorder whose symptomatology induces a modification of the
      intestinal microbiota. To date, studies have shown variable profiles without linking them to
      metabolic and neuropsychological energy phenotyping. This intestinal dysbiosis could be
      involved in the maintenance of the disorders. Bidirectional communication channels exist
      between the microbiota, the intestine and the brain. Anomalies in these pathways could
      explain the impact of the microbiota on the pathophysiology of anorexia nervosa. Therapeutic
      interventions would then be possible to restore the microbiota in anorexia nervosa and
      influence the treatment of this disease. This study aims to explore the hypothesis of
      disruption of the microbiota-intestinal-brain axis transversely and measuring the intestinal
      microbiota, urinary metabolome, biological factors nutritional, immunological and
      physiological plasma plasma of the intestine, and finally, the psychological dimensions
      characteristic of anorexia nervosa.
    </textblock>
  </brief_summary>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">September 2019</start_date>
  <completion_date type="Anticipated">February 2020</completion_date>
  <primary_completion_date type="Anticipated">December 2019</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Other</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>determination of bacterial microbiological profile by 16s sequencing of stool samples</measure>
    <time_frame>at inclusion</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Determination of the metabolomic profile</measure>
    <time_frame>at inclusion</time_frame>
    <description>evaluated by mass spectrometry (MS/MS) of urine</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Neurocognitive evaluation</measure>
    <time_frame>at 2 months</time_frame>
    <description>evaluated with questionnaire go-nogo</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Neurocognitive evaluation</measure>
    <time_frame>at 2 months</time_frame>
    <description>evaluated with questionnaire of flexibility</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Neurocognitive evaluation</measure>
    <time_frame>at 2 months</time_frame>
    <description>evaluated with questionnaire : food troop</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Neurocognitive evaluation</measure>
    <time_frame>at 2 months</time_frame>
    <description>evaluated with questionnaires : implicit and explicit evaluation.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Psychometric scaling for thymic evaluation</measure>
    <time_frame>at 2 months</time_frame>
    <description>evaluated with questionnaire : Child Depression Inventory</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Psychometric scaling for thymic evaluation</measure>
    <time_frame>at 2 months</time_frame>
    <description>evaluated with questionnaire : Hamilton Depression Rating Scale</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Determination of the plasma profile of intestinal physiology markers and immunological markers</measure>
    <time_frame>at inclusion</time_frame>
    <description>Intestinal permeability markers: ASCA, antiglycan, anti GP2 IgG/IgA, calprotectin</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Determination of the plasma profile of intestinal physiology markers and immunological markers</measure>
    <time_frame>at inclusion</time_frame>
    <description>immunoglobulin repertoire: A and M, inflammatory molecules: C-reactive protein</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Determination of the plasma profile of intestinal physiology markers and immunological markers</measure>
    <time_frame>at inclusion</time_frame>
    <description>circulating interleukins of the Th17 profile: IL17, IL23, IL6, IL1β, IL 22, IL21, IL33, IL31, TNFα, IFNγ, IL9, IL10, IL4.</description>
  </secondary_outcome>
  <number_of_groups>4</number_of_groups>
  <enrollment type="Anticipated">52</enrollment>
  <condition>Anorexia Nervosa</condition>
  <condition>Eating Disorder</condition>
  <arm_group>
    <arm_group_label>restrictive anorexia nervosa with hunger</arm_group_label>
  </arm_group>
  <arm_group>
    <arm_group_label>restrictive anorexia nervosa without hunger</arm_group_label>
  </arm_group>
  <arm_group>
    <arm_group_label>constitutional thinness</arm_group_label>
  </arm_group>
  <arm_group>
    <arm_group_label>control subjects without eating disorders</arm_group_label>
  </arm_group>
  <intervention>
    <intervention_type>Biological</intervention_type>
    <intervention_name>blood sampling</intervention_name>
    <description>12 ml sample</description>
    <arm_group_label>constitutional thinness</arm_group_label>
    <arm_group_label>control subjects without eating disorders</arm_group_label>
    <arm_group_label>restrictive anorexia nervosa with hunger</arm_group_label>
    <arm_group_label>restrictive anorexia nervosa without hunger</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>stool sampling</intervention_name>
    <description>20 g sample</description>
    <arm_group_label>constitutional thinness</arm_group_label>
    <arm_group_label>control subjects without eating disorders</arm_group_label>
    <arm_group_label>restrictive anorexia nervosa with hunger</arm_group_label>
    <arm_group_label>restrictive anorexia nervosa without hunger</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>urine sampling</intervention_name>
    <description>18 ml sample</description>
    <arm_group_label>constitutional thinness</arm_group_label>
    <arm_group_label>control subjects without eating disorders</arm_group_label>
    <arm_group_label>restrictive anorexia nervosa with hunger</arm_group_label>
    <arm_group_label>restrictive anorexia nervosa without hunger</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Diagnostic Test</intervention_type>
    <intervention_name>neuropsychological tests</intervention_name>
    <description>Go-nogo
flexibility
food stroop
implicit and explicit evaluation
Child Depression Inventory
Hamilton Depression Rating Scale</description>
    <arm_group_label>constitutional thinness</arm_group_label>
    <arm_group_label>control subjects without eating disorders</arm_group_label>
    <arm_group_label>restrictive anorexia nervosa with hunger</arm_group_label>
    <arm_group_label>restrictive anorexia nervosa without hunger</arm_group_label>
  </intervention>
  <biospec_retention>Samples With DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      -  20 g of stool

        -  18 ml of urines

        -  12 ml of blood
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        -  anorexia nervosa with and without hunger

          -  constitutional leanness

          -  control subjects
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion criteria common to all four groups

          -  Patient affiliated or entitled to a social security scheme

          -  Patient who received informed information about the study

          -  Patient does not object to participating in the study

        Inclusion criteria specific to mental anorexia

          -  BMI between 13 and 17.5 kg/m2

          -  Diagnostic and Statistical Manual of Mental Disorders IV restrictive anorexia nervosa
             diagnostic criteria

          -  Evolution of the troubles since less than 1 year.

          -  with feeling of hunger: &quot;hunger&quot; = total score on the 24-hour hunger scale &gt; 15 and
             presence of the three prandial peaks (score = 3)

          -  having lost the feeling of hunger: &quot;not hungry&quot; = total score on the 24-hour hunger
             scale ≤ 5 and absence of the three prandial peaks (score ≤ 2)

        Inclusion criteria specific to constitutionally thin patients

          -  BMI between 13 and 17.5 kg/m2

          -  Stable weight for at least 3 months

          -  No eating disorder

          -  No markers of undernutrition

        Inclusion criteria specific to normal weight subjects

          -  20 kg/m2 ≤ BMI ≤ 25 kg/m2

          -  Stable weight for at least 3 months

          -  No eating disorder

          -  No markers of undernutrition

        Non-inclusion criteria for all subjects :

          -  Antibiotic treatment during the 2 months preceding the sampling.

          -  History of immune system/autoimmune disease: Immune deficiency, Crohn's disease,
             systemic lupus erythematosus, rheumatoid arthritis, multiple sclerosis, psoriasis,
             Behçet's disease, celiac disease, type I diabetes.

          -  History of metabolic pathology: intestinal malabsorptive disease

          -  Medical or surgical history deemed by the investigator to be incompatible with this
             study.

          -  Severe progressive condition other

          -  Pregnant woman

          -  Majors under guardianship or subjects deprived of their liberty by judicial or
             administrative decision

          -  Ongoing psychotropic treatment

          -  Progressive diarrhea (Bristol Type V and VI)
      </textblock>
    </criteria>
    <gender>Female</gender>
    <gender_based>Yes</gender_based>
    <gender_description>only female</gender_description>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>30 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Natacha GERMAIN</last_name>
    <role>Principal Investigator</role>
    <affiliation>CHU de Saint Etienne</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Natacha GERMAIN</last_name>
    <phone>0477127727</phone>
    <phone_ext>+33</phone_ext>
    <email>natacha.germain@chu-st-etienne.fr</email>
  </overall_contact>
  <location>
    <facility>
      <name>Chu Saint-Etienne</name>
      <address>
        <city>Saint-Etienne</city>
        <zip>42055</zip>
        <country>France</country>
      </address>
    </facility>
    <contact>
      <last_name>Natacha GERMAIN</last_name>
      <phone>0477127727</phone>
      <phone_ext>+33</phone_ext>
      <email>natacha.germain@chu-st-etienne.fr</email>
    </contact>
    <investigator>
      <last_name>Bogdan GALUSCA, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Stéphane PAUL, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Natacha GERMAIN, PU-PH</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Catherine MASSOUBRE, PU-PH</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>November 2018</verification_date>
  <study_first_submitted>November 2, 2018</study_first_submitted>
  <study_first_submitted_qc>November 7, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">November 9, 2018</study_first_posted>
  <last_update_submitted>July 23, 2019</last_update_submitted>
  <last_update_submitted_qc>July 23, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">July 24, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>stool</keyword>
  <keyword>constitutional thinness</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Anorexia</mesh_term>
    <mesh_term>Feeding and Eating Disorders</mesh_term>
    <mesh_term>Anorexia Nervosa</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

